Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

NAPSA Antikörper (AA 189-299)

NAPSA Reaktivität: Human WB, IF, FACS, IHC (f) Wirt: Maus Monoclonal NAPSA-1238-NAPSA-1239 unconjugated
Produktnummer ABIN6938012
  • Target Alle NAPSA Antikörper anzeigen
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Bindungsspezifität
    • 13
    • 9
    • 8
    • 6
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 189-299
    Reaktivität
    • 76
    • 17
    • 9
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human
    Wirt
    • 51
    • 26
    Maus
    Klonalität
    • 47
    • 30
    Monoklonal
    Konjugat
    • 45
    • 7
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser NAPSA Antikörper ist unkonjugiert
    Applikation
    • 50
    • 31
    • 31
    • 15
    • 14
    • 11
    • 7
    • 6
    • 5
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))
    Spezifität
    Napsin is a pepsin-like aspartic proteinase connected with maturation of surfactant protein B.There are two closely related napsins, napsin A and napsin B. Napsin A is expressed as a single chain protein. Immunohistochemical studies revealed high expression levels of napsin A in human lung and kidney but low expression in spleen. Napsin A is expressed in type II pneumocytes and in adenocarcinomas of lung. The high specificity expression of napsin A in adenocarcinomas of lung is useful to distinguish primary lung adenocarcinomas from adenocarcinomas of other organs.
    Kreuzreaktivität (Details)
    Human.
    Aufreinigung
    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
    Immunogen
    Recombinant human Napsin-A protein fragment (aa189-299) (exact sequence is proprietary)
    Klon
    NAPSA-1238-NAPSA-1239
    Isotyp
    IgG kappa
    Top Product
    Discover our top product NAPSA Primärantikörper
  • Applikationshinweise

    Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Western Blot (1-2 μg/mL for 60 minutes at RT), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: Lung adenocarcinoma.

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    Prepared in 10 mM PBS, WITHOUT BSA and Azide.
    Konservierungsmittel
    Azide free
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
    Haltbarkeit
    24 months
  • Target
    NAPSA (Napsin A Aspartic Peptidase (NAPSA))
    Andere Bezeichnung
    NAPSA (NAPSA Produkte)
    Synonyme
    KAP antikoerper, Kdap antikoerper, NAP1 antikoerper, NAPA antikoerper, SNAPA antikoerper, pronapsin antikoerper, kap antikoerper, kdap antikoerper, nap1 antikoerper, napa antikoerper, napsa antikoerper, snapa antikoerper, napsin A aspartic peptidase antikoerper, napsin A aspartic peptidase L homeolog antikoerper, NAPSA antikoerper, Napsa antikoerper, napsa.L antikoerper
    Hintergrund
    ASP4, Aspartyl protease 4, KAP, Kidney derived aspartic protease like protein (Kdap), NAP1, NAPA, Napsa, napsin A aspartic peptidase, Pronapsin A, SNAPA,Napsin A (Lung Adenocarcinoma Marker)
    Cellular localisation: Cytoplasmic
    Molekulargewicht
    37kDa
    Gen-ID
    9476, 512843
    UniProt
    O96009
    Pathways
    Tube Formation, Asymmetric Protein Localization, Embryonic Body Morphogenesis
Sie sind hier:
Kundenservice